Infographic: Top 10 myths about working with FDA for oncology drug approval
How can you establish a clinical strategy for scientific and commercial success? Understanding the FDA is a big part of that. With 80+ former regulators within our 1000+ strong consulting team, we speak from first-hand experience.
Related Insights
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Webinar
Advancing mRNA-based drug development and vaccine manufacturing
Jul 1, 2024
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023
Related Insights
Blog
PD-1 inhibitors face scrutiny in esophageal cancer: Key takeaways for drug developers
Oct 4, 2024
Blog
Making cell and gene therapy more accessible in the treatment of solid tumors
Jun 4, 2024
Blog
Navigating the path to conditional approval: avoiding pitfalls in oncology drug applications
Feb 4, 2025
Webinar
Advancing mRNA-based drug development and vaccine manufacturing
Jul 1, 2024
Article
Five strategies for meeting the requirements of Project Optimus and improving the chances of approval
Nov 10, 2022
Webinar
Navigating the complexities of AML drug development
Oct 30, 2024
Article
Q&A Project Optimus: What you need to know
Oct 11, 2022
Webinar
Accelerating delivery of radiopharmaceutical trials
Oct 3, 2025
Webinar
Challenges and best practices for developing Antibody-Drug Conjugates (ADCs)
Nov 12, 2024
Blog
Assessing the need for comparative clinical trials in biosimilar development programs
Sep 21, 2023
Whitepaper
Scientific Validity Reports: a mandatory requirement for In Vitro Diagnostic Regulation (IVDR)
Sep 19, 2023
Blog
Studying rare cancer patient populations using integrated genomic and real-world data
Aug 30, 2023